Target intelligence / Profile preview

Microbial biomolecules

Molecular classification
Other
01

Overview

The term Broad microbial biomolecules via oxidative chemistry refers to a collective target class encompassing various essential components of pathogens—including proteins, lipids, and nucleic acids—that are susceptible to oxidative damage. This target is primarily addressed by broad-spectrum oxidizing agents such as antiseptics and disinfectants, rather than highly selective small molecules (1). These agents generate reactive oxygen species (ROS) or directly oxidize molecular structures, leading to the denaturation of enzymes, disruption of the lipid bilayer, and fragmentation of genomic material (2, 3). Because this mechanism of action is non-specific and physical-chemical in nature, it is effective against a wide array of bacteria, viruses, and fungi, and it is associated with a very low risk of antimicrobial resistance (4). However, the lack of selectivity means that these agents can also affect host cells, which generally restricts their therapeutic use to topical applications, wound care, and environmental sterilization (5). In clinical practice, targeting these biomolecules is a cornerstone of infection prevention in surgical and outpatient settings.

Other names
Microbial cell componentsBacterial proteins, lipids, and DNAPathogen biomoleculesOxidative targets of biocides
02

Mechanism of action

Oxidation of functional groups (such as thiols) in proteins, peroxidation of membrane lipids, and oxidative degradation of nucleic acids, leading to irreversible structural damage and microbial death.

03

Biological functions

Microbial metabolismStructural integrityGenetic replicationCell signaling
04

Disease associations

Infection
05

Safety considerations

Non-specific host tissue toxicitySkin and mucosal irritationDelayed wound healing at high concentrationsRisk of systemic absorption and toxicity
06

Interacting drugs

Hydrogen peroxide

6 more in the full profile.

07

Biomarkers

Microbial loadC-reactive proteinProcalcitoninWound healing rate

Beyond the preview

Go deeper on Microbial biomolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial biomolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call